Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YSPSL for Prevention of Ischemic Reperfusion Injury in Liver Transplantation
NCT00450398Phase 2Unknown
- Start
- Mar 2007
- Primary completion
- Dec 2007
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of rPSGL-Ig in ischemia-reperfusion injury (IRI). Status: unknown.
02
Drugs
rPSGL-Ig
03
Conditions
ischemia-reperfusion injury (IRI)
Beyond the preview
Go deeper on NCT00450398.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00450398.